Phase1 Study of TS-141 in Healthy Volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080225139

Enrollment

Registered

2020-03-25

Start date

2014-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : TS-141 INN of investigational material : - Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for In

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy Volunteers

Exclusion criteria

Exclusion criteria: Patients with a current medical history or medical history deemed inappropriate for participation in this study

Design outcomes

Primary

Measure	Time frame
safety pharmacokinetics To investigate Pharmacokinetics parameter of TS-141 and its metabolite To investigate incidence of Treatment-emergent Adverse Events and Serious AEs, vital-sign, weight, 12-leads ECG and clinical laboratory test	—

Countries

Japan

Outcome results